960 articles in this topic
The EPICURO trial tests MERIVA® turmeric over 6 months to see if it protects cognition in adults with metabolic syndrome.
New research maps beat-by-beat BP spikes following each apnea episode, revealing cardiovascular stress invisible to standard sleep studies.
A liver enzyme released during exercise may rejuvenate brain blood vessels and protect against cognitive decline and Alzheimer's pathology.
A large UK Biobank study finds sleep duration, napping, and sleeplessness independently predict white matter damage tied to dementia risk.
A randomized study finds that disclosing financial compensation during recruitment calls lowered consent rates by up to 13 points in Alzheimer's research.
A Harvard-developed digital seed amplification assay can precisely quantify TDP-43 protein aggregates in CSF, offering a potential diagnostic breakthrough for frontotemporal dementia.
JAMA publishes a poem exploring the intersection of medicine and verse, reflecting on the human dimensions of clinical practice.
A short literary piece in JAMA offers a humanizing perspective on clinical care and the patient-physician relationship.
Scientists image NMDA receptors at atomic resolution, uncovering how calcium enters and magnesium blocks the channel underlying neuroplasticity.
New research links excess astrocytic cholesterol to impaired brain clearance — a potential key mechanism driving Alzheimer's progression.
Arginine supplements reduced toxic amyloid buildup, brain inflammation, and behavioral decline in fly and mouse Alzheimer's models.
A roundup of recent FDA brain-health approvals including lecanemab's full Alzheimer's approval and a new glioma drug.
